(2S,3S,4R,5R)-5-(6-(6-(5-(dimethylamino)naphthalene-1-sulfonamido)hexylamino)-9H-purin-9-yl)-N-ethyl-3,4-dimethyltetrahydrofuran-2-carboxamide

ID: ALA2413105

PubChem CID: 73355132

Max Phase: Preclinical

Molecular Formula: C32H44N8O4S

Molecular Weight: 636.82

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCCCCCCNS(=O)(=O)c4cccc5c(N(C)C)cccc45)ncnc32)[C@H](C)[C@@H]1C

Standard InChI:  InChI=1S/C32H44N8O4S/c1-6-33-31(41)28-21(2)22(3)32(44-28)40-20-37-27-29(35-19-36-30(27)40)34-17-9-7-8-10-18-38-45(42,43)26-16-12-13-23-24(26)14-11-15-25(23)39(4)5/h11-16,19-22,28,32,38H,6-10,17-18H2,1-5H3,(H,33,41)(H,34,35,36)/t21-,22+,28-,32+/m0/s1

Standard InChI Key:  KNRSFVWCPNVINE-GMQMBVSESA-N

Molfile:  

     RDKit          2D

 45 49  0  0  0  0  0  0  0  0999 V2000
   12.6840   -3.1372    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.2756   -2.4247    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   11.8629   -3.1346    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.9929   -2.0159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4184   -1.1936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9880   -1.1943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4173   -2.0194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7056   -2.4281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7046   -3.2468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4146   -3.6579    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1269   -3.2443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1244   -2.4269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8379   -2.0130    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.6999   -0.7776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8363   -1.1882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5532   -2.4240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8396   -3.6620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8396   -4.4911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5596   -4.9035    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2753   -4.4911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2753   -3.6620    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.5596   -3.2495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0551   -3.4091    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5662   -4.0745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0551   -4.7481    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7980   -5.5328    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0094   -5.7897    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.0094   -6.6188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7980   -6.8718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2828   -6.2022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1118   -6.2022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0551   -7.6605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3398   -7.1035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5855   -6.7660    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4287   -7.9258    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9158   -7.2548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1615   -6.9173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5596   -2.4205    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2753   -2.0080    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9895   -2.4211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7041   -2.0092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4182   -2.4223    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1328   -2.0104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8469   -2.4235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5617   -2.0116    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  2  4  1  0
  4  8  2  0
  7  5  2  0
  5 14  1  0
  6  4  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 12 13  1  0
  6 14  2  0
 13 15  1  0
 13 16  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 17 23  1  0
 23 24  2  0
 24 25  1  0
 25 18  1  0
 26 25  1  1
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 26  1  0
 30 31  1  6
 29 32  1  6
 28 33  1  1
 33 34  1  0
 33 35  2  0
 34 36  1  0
 36 37  1  0
 22 38  1  0
 38 39  1  0
 39 40  1  0
 40 41  1  0
 41 42  1  0
 42 43  1  0
 43 44  1  0
 44 45  1  0
 45  2  1  0
M  END

Associated Targets(non-human)

Adora3 Adenosine A3 receptor (846 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adora2a Adenosine A2a receptor (3360 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adora1 Adenosine A1 receptor (6163 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 636.82Molecular Weight (Monoisotopic): 636.3206AlogP: 4.30#Rotatable Bonds: 14
Polar Surface Area: 143.37Molecular Species: NEUTRALHBA: 10HBD: 3
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 9.91CX Basic pKa: 5.00CX LogP: 3.95CX LogD: 3.95
Aromatic Rings: 4Heavy Atoms: 45QED Weighted: 0.17Np Likeness Score: -0.79

References

1. Kozma E, Jayasekara PS, Squarcialupi L, Paoletta S, Moro S, Federico S, Spalluto G, Jacobson KA..  (2013)  Fluorescent ligands for adenosine receptors.,  23  (1): [PMID:23200243] [10.1016/j.bmcl.2012.10.112]

Source